Literature DB >> 6749837

The elongation factor Tu binds aminoacyl-tRNA in the presence of GDP.

A Pingoud, W Block, A Wittinghofer, H Wolf, E Fischer.   

Abstract

Escherichia coli elongation factor (EF-Tu) binds aminoacyl-tRNAs (aa-tRNA) not only in the presence of GTP but also in the presence of GDP. Complex formation leads to a protection of the aa-tRNA against nonenzymatic deacylation and digestion by pancreatic ribonuclease, as well as to a protection of EF-Tu against proteolysis by trypsin. The equilibrium constant for the binding of Phe-tRNAPheyeast for example to EF-Tu.GDP has been determined to be 0.7 X 10(5) M-1 which is 2 orders of magnitude lower than the equilibrium constant for Phe-tRNAPheyeast binding to EF-Tu.GTP. In the presence of kirromycin, aminoacyl-tRNA binding to EF-Tu.GDP is not affected as much: Phe-tRNAPheyeast is bound with an equilibrium constant of 3 X 10(5) M-1. While there is also a measurable interaction between EF-Tu.GTP and tRNA, such an interaction cannot be detected with EF-Tu.GDP and tRNA, not even at millimolar concentrations. A so far undetected complex formation between aminoacyl-tRNA and EF-Tu.GTP in the presence of pulvomycin, however, could be detected. The results are discussed in terms of the structural requirements of ternary complex formation and in the light of proofreading schemes involving A-site binding on the E. coli ribosome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749837

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Preparation and evaluation of acylated tRNAs.

Authors:  Sarah E Walker; Kurt Fredrick
Journal:  Methods       Date:  2008-02       Impact factor: 3.608

2.  Photocrosslinking of the signal sequence of nascent preprolactin to the 54-kilodalton polypeptide of the signal recognition particle.

Authors:  U C Krieg; P Walter; A E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Zone-interference gel electrophoresis: a new method for studying weak protein-nucleic acid complexes under native equilibrium conditions.

Authors:  J P Abrahams; B Kraal; L Bosch
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

4.  Isolation and stability of ternary complexes of elongation factor Tu, GTP and aminoacyl-tRNA.

Authors:  J P Abrahams; B Kraal; B F Clark; L Bosch
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

5.  Effector region of the translation elongation factor EF-Tu.GTP complex stabilizes an orthoester acid intermediate structure of aminoacyl-tRNA in a ternary complex.

Authors:  C Förster; S Limmer; W Zeidler; M Sprinzl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Lack of discrimination against non-proteinogenic amino acid norvaline by elongation factor Tu from Escherichia coli.

Authors:  Nevena Cvetesic; Irena Akmacic; Ita Gruic-Sovulj
Journal:  Croat Chem Acta       Date:  2013       Impact factor: 0.887

7.  E. coli elongation factor Tu bound to a GTP analogue displays an open conformation equivalent to the GDP-bound form.

Authors:  Jesper S Johansen; Darius Kavaliauskas; Shawn H Pfeil; Mickaël Blaise; Barry S Cooperman; Yale E Goldman; Søren S Thirup; Charlotte R Knudsen
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

8.  The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.

Authors:  J R Mesters; L A Zeef; R Hilgenfeld; J M de Graaf; B Kraal; L Bosch
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

9.  Many of the conserved nucleotides of tRNA(Phe) are not essential for ternary complex formation and peptide elongation.

Authors:  I A Nazarenko; K M Harrington; O C Uhlenbeck
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

10.  Pulvomycin-resistant mutants of E.coli elongation factor Tu.

Authors:  L A Zeef; L Bosch; P H Anborgh; R Cetin; A Parmeggiani; R Hilgenfeld
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.